G20 leaders vow unity; to boost vaccine access to fight Covid-19 pandemic

To sign 'Declaration of Rome'- guiding principles that prioritise multilateralism

coronavirus, vaccine, vaccination, covid-19
The European Union promised to invest 1 billion euros ($1.2 billion) to set up vaccination manufacturing hubs in Africa
Agencies
3 min read Last Updated : May 22 2021 | 3:20 AM IST
Major drugmakers and rich nation leaders faced up on Friday to the startling global imbalance in fighting Covid-19 and made big pledges to up supplies of cut-price vaccines to poorer regions.

Lavishly-funded mass inoculation campaigns are helping the West and others slash infections, but few shots have reached poorer nations where the virus is still raging, sometimes uncontrollably, drawing accusations of "vaccine apartheid".

“If we do not close this immense gap, more people will die needlessly. There are two immediate actions countries can take: share dollars and doses,” Bill Gates said.

The summit was to call for voluntary licensing and technology transfers to boost vaccine production, but will sidestep a push from the United States and other nations to waive valuable patents, a joint declaration showed.


The European Union promised to invest 1 billion euros ($1.2 billion) to set up vaccination manufacturing hubs in Africa. 

China pledges billions

China’s President Xi Jinping pledged $3 billion in aid over the next three years to help developing countries recover from the pandemic and proposed setting up an international forum to promote fair distribution of vaccines.


Meanwhile, European Commission President Ursula von der Leyen said that the EU will make a proposal to facilitate the use of those clauses and added that Europe would donate at least 100 million doses to poorer nations by the end of the year, including 30 million each from France and Germany.

Leaders at the gathering were due to sign the so-called Declaration of Rome, a set of guiding principles ranging from ensuring fair distribution of vaccines to ramping up production and possibly using compulsory licenses.


WTO urges leaders to negotiate IP waiver

The head of the World Trade Organization (WTO) on Friday called on the leaders of the Group of 20 nations to make progress in negotiations on a proposal to waive intellectual property rights for Covid-19 vaccines.

Vaccine makers pledge 3.5 bn doses for poorer nations

Pfizer, Moderna, and J&J pledged over 3.5 billion doses of Covid-19 vaccines at cost or discount for poorer nations at the Global Health Summit. US pharma giant Pfizer said it will deliver around 2 billion doses over the next 18 months, which shall include over 1 billion doses in 2021 itself, its chief said.  Agencies


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusG20 nationsCoronavirus VaccineVaccinationVaccineintellectual property rights

Next Story